Comparison of interferonα2β monotherapy with the combination of thymosinα1 and interferonα2β in the treatment of anti-HBe-positive chronic hepatitis B in Turkey.

Simple item page
dc.contributor.authorSaruc, M
dc.contributor.authorYuceyar, H
dc.contributor.authorKucukmetin, N
dc.contributor.authorDemir, MA
dc.contributor.authorKandiloglu, AR
dc.date.accessioned2025-04-10T10:25:52Z
dc.date.available2025-04-10T10:25:52Z
dc.identifier.issn0016-5085
dc.identifier.urihttp://hdl.handle.net/20.500.14701/33601
dc.language.isoEnglish
dc.titleComparison of interferonα2β monotherapy with the combination of thymosinα1 and interferonα2β in the treatment of anti-HBe-positive chronic hepatitis B in Turkey.
dc.typeMeeting Abstract

Files

Collections

Web of Science Koleksiyonu